Genetec Technology Berhad (KLSE:GENETEC)

Genetec Technology Berhad Statistics

Total Valuation

KLSE:GENETEC has a market cap or net worth of MYR 119.83 million. The enterprise value is 164.37 million.

Market Cap	119.83M
Enterprise Value	164.37M

Important Dates

The last earnings date was Monday, February 23, 2026.

Earnings Date	Feb 23, 2026
Ex-Dividend Date	n/a

Share Statistics

KLSE:GENETEC has 773.12 million shares outstanding. The number of shares has increased by 1.84% in one year.

Current Share Class	773.12M
Shares Outstanding	773.12M
Shares Change (YoY)	+1.84%
Shares Change (QoQ)	+0.34%
Owned by Insiders (%)	21.52%
Owned by Institutions (%)	26.02%
Float	562.56M

Valuation Ratios

PE Ratio	n/a
Forward PE	3.84
PS Ratio	0.67
PB Ratio	0.37
P/TBV Ratio	0.37
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-1.07
EV / Sales	0.91
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-1.20

Financial Position

The company has a current ratio of 2.14, with a Debt / Equity ratio of 0.31.

Current Ratio	2.14
Quick Ratio	2.04
Debt / Equity	0.31
Debt / EBITDA	n/a
Debt / FCF	-0.73
Interest Coverage	-62.95

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	n/a
Return on Invested Capital (ROIC)	-36.14%
Return on Capital Employed (ROCE)	-44.64%
Weighted Average Cost of Capital (WACC)	1.27%
Revenue Per Employee	521,823
Profits Per Employee	-445,359
Employee Count	345
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	-871,000
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -86.04% in the last 52 weeks. The beta is -0.62, so KLSE:GENETEC's price volatility has been lower than the market average.

Beta (5Y)	-0.62
52-Week Price Change	-86.04%
50-Day Moving Average	0.26
200-Day Moving Average	0.56
Relative Strength Index (RSI)	15.72
Average Volume (20 Days)	4,950,810

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, KLSE:GENETEC had revenue of MYR 180.03 million and -153.65 million in losses. Loss per share was -0.20.

Revenue	180.03M
Gross Profit	-105.05M
Operating Income	-143.65M
Pretax Income	-147.24M
Net Income	-153.65M
EBITDA	-139.94M
EBIT	-143.65M
Loss Per Share	-0.20

Balance Sheet

The company has 56.00 million in cash and 100.54 million in debt, with a net cash position of -44.53 million or -0.06 per share.

Cash & Cash Equivalents	56.00M
Total Debt	100.54M
Net Cash	-44.53M
Net Cash Per Share	-0.06
Equity (Book Value)	320.96M
Book Value Per Share	0.42
Working Capital	176.55M

Cash Flow

In the last 12 months, operating cash flow was -111.87 million and capital expenditures -25.10 million, giving a free cash flow of -136.96 million.

Operating Cash Flow	-111.87M
Capital Expenditures	-25.10M
Free Cash Flow	-136.96M
FCF Per Share	-0.18

Margins

Gross margin is -58.35%, with operating and profit margins of -79.79% and -85.35%.

Gross Margin	-58.35%
Operating Margin	-79.79%
Pretax Margin	-81.78%
Profit Margin	-85.35%
EBITDA Margin	-77.73%
EBIT Margin	-79.79%
FCF Margin	n/a

Dividends & Yields

KLSE:GENETEC does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	1
Payout Ratio	n/a
Buyback Yield	-1.84%
Shareholder Yield	-1.84%
Earnings Yield	-128.22%
FCF Yield	-114.29%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on January 7, 2022. It was a forward split with a ratio of 13.

Last Split Date	Jan 7, 2022
Split Type	Forward
Split Ratio	13

Scores

KLSE:GENETEC has an Altman Z-Score of 2.54 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	2.54
Piotroski F-Score	2